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Main Findings
■ The expansion of nurse prescribing has benefited patients, improved public health and benefited health care professionals in
many ways.
■ These benefits include improved patient access to treatment, enhanced patient care, maintaining and improving patient
experience, enhanced professional satisfaction and application of nurse skills, building inter-professional working, enabling
effective use of medical staff time, and maintaining public health standards.
■ Although nurse prescribing and its expansion appear to have succeeded the depth and breadth of that success varies and the
study indentifies some obstacles that may restrict the successes of nurse prescribing. Such variations may be partly due to
institutional and resource factors as well as personal and professional attitudes and organisational factors.
■ The evidence indicates that in some settings nurse prescribing could be rolled out even further and have a greater beneficial
impact on patients, their carers and health professionals and administrative teams if some of the obstacles were removed, if
best practice could be more readily exchanged and if communication and support networks could be further facilitated.
■ Nowhere in the survey, case studies or stakeholder interviews were any nurse prescribing incidents or problems reported that
affected patient safety.  However, stakeholder groups, the health professionals themselves and their managers all identified
the need for effective education, supervision and auditing of nurse prescribing work.  
■ For senior managers, this was viewed as an essential part of effective clinical governance.  How extensive and exactly how
effective such governance of nurse prescribers is may require further research.  
■ The capacity to demonstrate good governance at all levels and locations of nurse prescribing would provide important and
necessary re-assurance for the prescribers themselves, the other health professionals they work with, the patients and public
at large, user stakeholder groups and the Scottish Government.
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Nurse prescribing first became part of the UK government’s policy agenda following the Cumberlege Report (DHSS, 1986).
By 2001, nurse prescribing was extended to include more nurses and to cover a wider formulary.  Nurse prescribers in
Scotland can now prescribe a range of controlled drugs for specific medical conditions. This research project which is
summarised below provides an evaluation of the extension of nurse prescribing following the introduction of new legislation
in 2001.
Introduction
Nurse prescribing first became part of the UK government’s
policy agenda following the Cumberlege Report (DHSS,
1986). By 2001, nurse prescribing was extended to
include more nurses and to cover a wider formulary. Nurse
prescribers in Scotland can now prescribe a range of
controlled drugs for specific medical conditions.
This research project provides an evaluation of the
extension of prescribing powers to nurses following the
introduction of new legislation in 2001 and aimed to
examine:
 The implementation and operation of the extension of
nurse prescribing;
 The impact of nurse prescribing on the appropriate use of
nurses’ skills;
 Patient benefit from nurse prescribing and patients’
perceptions of their experiences of care;
 The impact of nurse prescribing extension on workloads;
 The extent to which public health and patient safety are
safeguarded; and
 Different approaches to nurse prescribing training.
Methods
A variety of methods were used to achieve the project
objectives across two main areas of evaluation: nurse
prescribing in practice and preparing for prescribing.
The evaluation of nurse prescribing in practice included:
 Stakeholder interviews and meetings;
 A postal questionnaire of all nurses Nursing and Midwifery
Council database who prescribe;
 Two surveys of the public;
 Case studies involving nurse prescribers across acute and
primary care settings, patients, other health professionals
and managers using in depth interviews across Scotland.
The exploration of nurse prescribing education also used a
mixture of methods including:
 Documentary analysis;
 A questionnaire;
 Interviews; and
 Focus groups supplemented by case histories and diaries.
Findings: Nurse prescribing in
practice
Patient Care
Patient care had been improved by nurse prescribing,
particularly in specialist areas and areas of particular
competence. The public generally showed considerable
confidence in the nurse prescribing processes that they
experienced.
Nurse prescribing made patient care both quicker and
easier. Patients placed more value on getting appropriate
and effective care than on the qualifications of the person
providing the care. Patients also found benefits through
better inter-professional liaison about their care and tended
to prefer team working rather than autonomous practice.
Patients receiving ‘complete packages’ of care, particularly
patients with complex health needs who required daily care,
found additional benefit from nurses prescribing. This also
benefited carers.
Respondents felt that patients benefited when nurses’ skills
in assessment, observation and diagnosis were improved as
a result of learning to prescribe.
Nurse prescribers identified improved consultation skills and
contact opportunities to educate patients and promote
health as well as to discuss aspects of medication such as
side effects and correct administration of treatments like
asthma inhalers. This it was felt contributed to improved
patient self-care abilities especially in mental health. Nurses’
familiarity with medication developed through more careful
use of the BNF together with practice in writing
prescriptions.
Nurse prescribers’ public health contributions were
recognised by medical and nursing staff. The benefits to
infection control and better treatment of conditions without
the use of anti-microbial drugs or with more careful targeting
of microbial drugs were also recognised. Nurses felt that
they had further and more expanded roles, for example in
smoking cessation and sexual health areas.
The evaluation found that there was however patchy
geographical or professional implementation of nurse
prescribing.
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Professional impacts of nurse prescribing
The professional benefits associated with nurse prescribing
related to increased satisfaction, improved professional
development and a related increase in professional
recognition and respect.  Benefits were seen to be
contingent on CPD, support and resources, including
allocated time for studying, ongoing support and education
and budgetary resources.
Effective support for nurse prescribers included informal
colleague support, information from and close working with
pharmacists, and positive GP/medical feedback.
Pharmacists and health service managers generally found
nurse prescribing of benefit to practices and patients.
Respondents felt that it ensured a more rapid accessible
service for patients with certain conditions.
Some hospital doctors and GPs championed both current
nurse prescribing and its extension because of benefits for
the public, the NHS, application of nurse skills and workloads
across several groups.  Rural GPs found major benefits to
manageable workloads through the expansion of nurse
prescribing.
Hindrances to nurse prescribing practice often centred on
administrative issues, including budget and budgetary
allocation issues which resulted in major delays in receiving
prescription pads and difficulties with prescriptions not being
computerised.
The medical profession generally found the extension of
nurse prescribing to be safe, of benefit to patients and to
themselves.  
Nurse prescribers reported that their work had reduced
doctor’s workloads, but at the same time concerns were
expressed about increased workloads for nurse prescribers.
Nurse prescribers had some fears about nurse prescribing
becoming ‘overly medicalised’ and felt it important to retain
traditional nursing roles in future prescribing developments.
Management and co-ordination of nurse
prescribing
There sometimes appeared to be a lack of a coherent,
integrated and stable Board level infrastructure for
prescribers. In some instances, it was felt that this
demonstrated a slow response to the prescribing agenda.
Linked to this, some stakeholders perceived a lack of a
joined up approach running from the Scottish Government,
through NHS Boards and down to the prescribers
themselves.  Some NHS Boards lacked any leads or had
leads only for some sectors.  Some stakeholders identified
a lack of strategic leadership to carry through prescribing in
under-developed midwifery and mental health areas.
The collaboration between post holders at NHS board level,
such as medical directors, directors of pharmacy and lead
nurse prescribers was vital, but at times it was felt this was
lacking.  To some, it appeared that nurse prescribing
especially outwith the primary care sector was still on the
margins of the administrative system.
Systems for reviewing and monitoring prescribing practice
across Scotland appeared to be assumed, but not always
tested. In addition, there was no obvious and suitable
medicines management system in place to track the costs of
prescribing accurately and document any related benefits.  
The need to have CPD to ensure prescribers’ fitness for
practice was identified by respondents.  Contradictory views
were expressed about the need for personal formularies and
for generic versus specific courses for particular courses.
However, among the stakeholders, the overwhelming
consensus was for a generic course supplemented with CPD
opportunities at key intervals. 
Findings: Nurse prescribing
Education
The most important aspect of the courses according to the
focus group participants, was that it enhanced the course
members’ professional knowledge and expertise. The
second most important feature of the courses was that it
enabled them to acquire a systematic understanding of
pharmacology. This it was felt increased patient safety and
facilitated communication with doctors and pharmacists.
Thus, based on the course members’ point of view, the
courses was felt to be ‘fit for purpose’. 
The courses presented a generic model of nurse prescribing
and taught a broad underpinning knowledge of
pharmacology.  Whilst there was evidence that some nurses
expected a much narrower course of training, focused on the
contexts in which they worked and limited to the actual drugs
they would be prescribing, the evaluation found strong
reasons for retaining the generic structure.  These included
preparing nurses to deal with patients with multiple illnesses
and supporting the trend towards collaborative practice.  
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Additionally, course members valued the opportunity
provided by the generic nature of the course to network with
nurses from other specialties, which enhanced their capacity
to work collaboratively.
Mentoring was largely viewed positively, however there were
cases of both nurses and mentors who found it extremely
difficult to get any allocated time for mentoring.  Mentors
also reported difficulties in knowing what was expected of
their role.  Suggested solutions included the use of two
mentors:  one clinical and one nurse prescriber who had
experienced the prescribing course. 
Conclusions
There is a high level of agreement between patients, the
public, nurse prescribers, physicians and other health
professionals and health managers about the benefits of
nurse prescribing to patients. However, some organisational
and procedural challenges remain to ensure the maximum
effectiveness of prescribing is fully achieved. Evidence
indicates that in some settings nurse prescribing could be
rolled out even further and have a greater beneficial impact
if some of the obstacles were removed, if best practice
could be more readily exchanged, and if communication and
support networks could be further facilitated.
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This document, along with “An Evaluation of the Extension of Independent Nurse Prescribing in Scotland” the full
research report of the project, and further information about social and policy research commissioned and
published on behalf of the Scottish Government, can be viewed on the Internet at:
http://www.scotland.gov.uk/socialresearch.  If you have any further queries about social research, please contact
us at socialresearch@scotland.gsi.gov.uk or on 0131-244 7560.
